immune system
• in vivo clearance of RMAS/CD48+ tumors cells is impaired compared to in wild-type mice
• NK cell RMAS/CD48+, P815/CD84+, or B16/CD84+ tumors cell killing is impaired in vivo compared with wild-type cells
• NK cell P815/CD48+ tumors cell killing is abolished in vivo compared with wild-type cells
• NK cells are defective in anti-CD244 dependent killing of 51Cr-labeled P815 cells compared with wild-type mice
• NK cells kill anti-CD84-coated P815 and B16 cells less efficiently killed compared to wild-type cells
• however, clearance of RMAS/CD48- tumor cells is normal and NK cells efficiently kill YB2/0, YAC-1, and CHO cells
|
• in NK cells stimulated by CD244 with anti-CD244 antibodies
• however, IFN-gamma production by NK cells stimulated by anti-Ly49D or anti-NKG2D stimulation
|
hematopoietic system
• in vivo clearance of RMAS/CD48+ tumors cells is impaired compared to in wild-type mice
• NK cell RMAS/CD48+, P815/CD84+, or B16/CD84+ tumors cell killing is impaired in vivo compared with wild-type cells
• NK cell P815/CD48+ tumors cell killing is abolished in vivo compared with wild-type cells
• NK cells are defective in anti-CD244 dependent killing of 51Cr-labeled P815 cells compared with wild-type mice
• NK cells kill anti-CD84-coated P815 and B16 cells less efficiently killed compared to wild-type cells
• however, clearance of RMAS/CD48- tumor cells is normal and NK cells efficiently kill YB2/0, YAC-1, and CHO cells
|